Neglected Tropical Diseases Drugs and Vaccines Market

Neglected Tropical Diseases Drugs and Vaccines Market by Vaccines (Dengue, Zika, and Malaria) and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa)- Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1829
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 2
  • No. Of Pages: 170
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global neglected tropical diseases drugs and vaccines market size was valued at USD 81.7 million in 2020 and is anticipated to expand at a CAGR of 10.3% during the forecast period, 2021-2028. The growth of the market is attributed to the increase in awareness of neglected tropical diseases and the extensive research and development activities towards the feasibility of providing these cures on a globally massive scale.

Neglected Tropical Diseases Drugs and Vaccines Market Key Takeaways

Neglected tropical diseases are considered to be a large diverse group of infections, primarily tropical in nature, commonly found in low-income populations. The main reason for the widespread of these diseases is malnutrition. Compared to most of the developed countries, the regions having neglected tropical diseases have limited healthcare infrastructure and thereby cannot diagnose highly infectious diseases such as the HIV/AIDS, malaria, and tuberculosis. These regions do not have access to the vaccines and drugs that can cure such infectious diseases.

According to the World Health Organization or the WHO, along with the Global Alliance for Vaccines and Immunization or the GAVI, one sixth of the global population is affected by the neglected tropical diseases till and this will only scale to larger values owing to the spread of the coronavirus. The COVID-19 pandemic has hindered the growth of the global neglected tropical diseases drugs and vaccines market initially. However, upon further studies, researchers and scientists found out that the coronavirus has the viral gene of accelerating illness of the hosts. This steered to hospitals, clinics, and healthcare laboratories to focus more on the development of neglected tropical diseases drugs and vaccines for the prevention and treatment of diseases and this led to its market growth in the later stages of this pandemic.

Market Trends, Drivers, Restraints, and Opportunities

  • Increase in spending and investing by the companies towards neglected tropical diseases drugs and vaccines is the primary reason for the projection of boosting the market growth during the forecast period, 2021-2028.
  • Rapid growth of foreign investment along with foundations and charities can become a major factor in the boosting of the global neglected tropical diseases drugs and vaccines market during the forecast period.
  • High prices for the development of neglected tropical diseases drugs and vaccines and high cost of services from the company’s perspective is anticipated to hinder the global market growth.
  • Neglected tropical diseases drugs and vaccines are largely being contributed by developed nations which are examined under different climate conditions to the tropical environments. These medicines need to be calibrated according to these conditions and a wrong assumption could lead to failure of these cures. This uncertainty can hamper the global market growth.
  • R&D investment and technological advancement are expected to offer significant opportunities for the market players. Merck & Co. Inc have offered to provide free vaccinations to the entire Japan population after the outbreak in 2017 for the period of five years, and currently even providing the vaccinations for the coronavirus.

Scope of the Report

The report on the global neglected tropical diseases drugs and vaccines market size includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Neglected Tropical Diseases Drugs and Vaccines Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Vaccines (Dengue, Zika, and Malaria)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Trends, and Revenue Forecast

Key Players Covered in the Report

GlaxoSmithKline plc; Takeda; Pfizer Inc.; Bayer AG; Sanofi; Merck & Co. Inc.; Bristol-Myers Squibb Company; Abbott; Novartis AG; Johnson & Johnson Services Inc.; Gilead Sciences Inc.; and Astellas Pharma Inc.

Global Neglected Tropical Diseases Drugs and Vaccines Market Segment Insights

Dengue segment is projected to represent a large market share

Based on vaccines, the global neglected tropical diseases drugs and vaccines market is divided into dengue, zika, and malaria. The dengue segment is expected to constitute the major share in 2019. The major reason attributing to this market growth is the outbreak of this disease which happened in 2012-2013 to three continents. This increased the demand for this disease vaccine and the distribution of this vaccination is still going as of 2020.

Meanwhile the zika segment is anticipated to grow with a significant CAGR during the forecast period, 2021-2028, owing to the phase II and phase III uncertainty and this disease being lethal, even death. This along with the coronavirus spread has made the zika segment to propel even further.

Neglected Tropical Diseases Drugs and Vaccines Market By Vaccines

Asia Pacific is anticipated to dominate the market

On the basis of regions, the global neglected tropical diseases drugs and vaccines market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market in Asia Pacific is expected to constitute a major share in 2020. This regional market growth can be attributed to the growing research & development expenditure along with the rising in adoption of the latest technology. The cost of expenditure is significantly lower in Asia Pacific than that of other economies. However, the market in Middle East & Africa is anticipated to expand at a significant CAGR during the forecast period, 2021-2028, as they have prioritized the cost-efficiency perspective of neglected tropical diseases drugs and vaccines combined with their growing population and increase in foreign investments.

Neglected Tropical Diseases Drugs and Vaccines Market By Regions

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Neglected Tropical Diseases Drugs and Vaccines Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Neglected Tropical Diseases Drugs and Vaccines Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Neglected Tropical Diseases Drugs and Vaccines Market - Supply Chain
  4.5. Global Neglected Tropical Diseases Drugs and Vaccines Market Forecast
     4.5.1. Neglected Tropical Diseases Drugs and Vaccines Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Neglected Tropical Diseases Drugs and Vaccines Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Neglected Tropical Diseases Drugs and Vaccines Market Absolute $ Opportunity
5. Global Neglected Tropical Diseases Drugs and Vaccines Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Neglected Tropical Diseases Drugs and Vaccines Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Neglected Tropical Diseases Drugs and Vaccines Demand Share Forecast, 2019-2026
6. North America Neglected Tropical Diseases Drugs and Vaccines Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Neglected Tropical Diseases Drugs and Vaccines Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Neglected Tropical Diseases Drugs and Vaccines Demand Share Forecast, 2019-2026
7. Latin America Neglected Tropical Diseases Drugs and Vaccines Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Neglected Tropical Diseases Drugs and Vaccines Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Neglected Tropical Diseases Drugs and Vaccines Demand Share Forecast, 2019-2026
8. Europe Neglected Tropical Diseases Drugs and Vaccines Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Neglected Tropical Diseases Drugs and Vaccines Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Neglected Tropical Diseases Drugs and Vaccines Demand Share Forecast, 2019-2026
9. Asia Pacific Neglected Tropical Diseases Drugs and Vaccines Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Neglected Tropical Diseases Drugs and Vaccines Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Neglected Tropical Diseases Drugs and Vaccines Demand Share Forecast, 2019-2026
10. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccines Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccines Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccines Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Neglected Tropical Diseases Drugs and Vaccines Market: Market Share Analysis
  11.2. Neglected Tropical Diseases Drugs and Vaccines Distributors and Customers
  11.3. Neglected Tropical Diseases Drugs and Vaccines Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. GlaxoSmithKline plc Takeda Pfizer Inc. Bayer AG Sanofi  
Segments Covered in the Report
The global neglected tropical diseases drugs and vaccines market size has been segmented in terms of

Vaccines
  • Dengue
  • Zika
  • Malaria
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • GlaxoSmithKline plc
  • Takeda
  • Pfizer Inc.
  • Bayer AG
  • Sanofi
  • Merck & Co. Inc.
  • Bristol-Myers Squibb Company
  • Abbott
  • Novartis AG
  • Johnson & Johnson Services Inc.
  • Gilead Sciences Inc.
  • Astellas Pharma Inc.

Major players competing in the global neglected tropical diseases drugs and vaccines market are GlaxoSmithKline plc; Takeda; Pfizer Inc.; Bayer AG; Sanofi; Merck & Co. Inc.; Bristol-Myers Squibb Company; Abbott; Novartis AG; Johnson & Johnson Services Inc.; Gilead Sciences Inc.; and Astellas Pharma Inc. These market players are involved in several business strategies such as mergers, acquisitions partnerships, collaborations, capacity expansion, and product launches to enhance their market shares. Takeda have announced the mass production of dengue vaccines to distribute on the global scale and have tied up with more than 30 distributors in 2020.

Neglected Tropical Diseases Drugs and Vaccines Market By Key Players

Buy Report